ADNOCDRILL earnings per share for the last quarter are 0.08 AED whereas the estimation was 0.07 AED which accounts for 4.84% surprise. Company revenue for the same period amounts to 3.77 B AED despite the estimated figure of 3.62 B AED. Estimated earnings per share for the next quarter are 0.07 AED, and revenue is expected to reach 3.71 B AED. Also watch annual changes over time to get a bigger picture of ADNOCDRILL earnings per share and revenue dynamics.